Study of the Safety and Efficacy of RVL-1201 in the Treatment of Acquired Blepharoptosis
Public ClinicalTrials.gov record NCT02436759. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Masked, Placebo-Controlled Phase 3 Study of the Safety and Efficacy of RVL-1201 in the Treatment of Acquired Blepharoptosis
Study identification
- NCT ID
- NCT02436759
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- RVL Pharmaceuticals, Inc.
- Industry
- Enrollment
- 140 participants
Conditions and interventions
Conditions
Interventions
- RVL-1201 Drug
- RVL-1201 Vehicle Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2015
- Primary completion
- Oct 31, 2016
- Completion
- Oct 31, 2016
- Last update posted
- Oct 27, 2021
2015 – 2016
United States locations
- U.S. sites
- 14
- U.S. states
- 7
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Artesia | California | 90701 | — |
| Not listed | Newport Beach | California | 92663 | — |
| Not listed | Rancho Cordova | California | 95670 | — |
| Not listed | Santa Maria | California | 93454 | — |
| Not listed | Fort Myers | Florida | 33901 | — |
| Not listed | Largo | Florida | 33773 | — |
| Not listed | Plantation | Florida | 33324 | — |
| Not listed | Sarasota | Florida | 34239 | — |
| Not listed | Roswell | Georgia | 30076 | — |
| Not listed | Pittsburg | Kansas | 66762 | — |
| Not listed | Shawnee Mission | Kansas | 66204 | — |
| Not listed | Mason | Ohio | 45040 | — |
| Not listed | Kingston | Pennsylvania | 18704 | — |
| Not listed | Nashville | Tennessee | 37215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02436759, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 27, 2021 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02436759 live on ClinicalTrials.gov.